Immunoglobulin A (IgA) Deficiency – A Comprehensive Medical Guide
Overview
Immunoglobulin A (IgA) deficiency is the most common primary antibody‑deficiency disorder. It occurs when the body produces very low levels of IgA, an antibody that plays a crucial role in protecting the mucous membranes of the respiratory, gastrointestinal, and genitourinary tracts. People with IgA deficiency are more prone to infections, autoimmune diseases, and allergic disorders.
- Prevalence: Affects roughly 1 in 300 to 1 in 700 individuals of European descent, but is less common in Asian and African populations (Mayo Clinic).
- Typical age of detection: Often identified in childhood or early adulthood when recurrent infections prompt laboratory testing.
- Gender: Slight male predominance (about 1.5 : 1), though data vary.
- Classification:
- Partial IgA deficiency – IgA levels < 7 mg/dL (but >0 mg/dL).
- Selective IgA deficiency – IgA < 7 mg/dL with normal levels of other immunoglobulins (IgG, IgM).
Symptoms
Many individuals with IgA deficiency remain asymptomatic, and the condition is discovered incidentally. When symptoms occur, they usually involve mucosal surfaces.
Infections
- Respiratory tract infections: Recurrent sinusitis, otitis media, bronchitis, and pneumonia.
- Gastrointestinal infections: Chronic or recurrent diarrhea, especially caused by Giardia lamblia or Campylobacter.
- Upper airway infections: Frequent pharyngitis, tonsillitis, or rhinitis.
Allergic and Autoimmune Manifestations
- Asthma, allergic rhinitis, and atopic dermatitis.
- Autoimmune diseases such as:
- Systemic lupus erythematosus (SLE)
- Rheumatoid arthritis
- Autoimmune thyroid disease (Hashimoto’s or Graves’)
- Celiac disease
Other Clinical Features
- Upper and lower gastrointestinal bleeding due to mucosal damage.
- Increased risk of anaphylactic reactions to blood products that contain IgA.
- Fatigue and reduced exercise tolerance related to chronic infections.
- Occasional developmental or growth delays in children with severe, untreated infections.
Causes and Risk Factors
IgA deficiency is primarily a genetic condition, but the exact cause remains incompletely understood.
Genetic Factors
- Most cases are sporadic, but familial clustering suggests inheritance patterns, often linked to the major histocompatibility complex (MHC) region on chromosome 6 (NIH).
- Associated with certain HLA haplotypes (e.g., HLA‑B8, DR3, DQ2).
Environmental Triggers
- Early‑life infections or exposure to certain viruses (e.g., Epstein‑Barr virus) may precipitate a decline in IgA production in genetically predisposed individuals.
- Some medications (e.g., anti‑TNF agents) have been reported to unmask or worsen IgA deficiency.
Risk Factors
- Family history of primary immunodeficiency.
- Coexisting autoimmune disease.
- Ethnicity: higher rates in people of Northern European descent.
- Male sex (modest increase).
Diagnosis
Because symptoms overlap with common infections, a high index of suspicion is needed.
Laboratory Evaluation
- Serum immunoglobulin panel: Quantitative measurement of IgA, IgG, and IgM. IgA < 7 mg/dL with normal IgG/IgM confirms selective deficiency.
- Vaccination response tests: Assess functional antibody production (e.g., response to pneumococcal polysaccharide vaccine).
- IgE and specific IgG subclasses: Helpful when evaluating allergy or autoimmune co‑morbidities.
Additional Tests
- Complete blood count (CBC) and differential – to look for neutropenia or eosinophilia.
- Stool ova & parasite exam – especially if chronic diarrhea is present.
- Bronchoscopy, sinus CT, or endoscopy – reserved for persistent infection or suspicion of structural disease.
- Allergy testing (skin prick or specific IgE) – frequently performed because of overlapping allergic symptoms.
Diagnostic Criteria (per WHO/ISAID)
- Serum IgA < 7 mg/dL (or < 0.07 g/L) on at least two separate occasions.
- Normal IgG and IgM levels.
- Absence of secondary causes (e.g., protein‑losing nephropathy, gastrointestinal protein loss, or certain medications).
Treatment Options
There is no cure for IgA deficiency; management focuses on preventing infections, treating complications, and addressing associated autoimmune disease.
Infection Management
- Antibiotics: Prompt, culture‑directed therapy for bacterial sinusitis, otitis media, or pneumonia. Prophylactic antibiotics (e.g., azithromycin 250 mg weekly) may be considered for patients with ≥4 serious infections per year (Cleveland Clinic).
- Antimicrobial prophylaxis for Giardia: Metronidazole 250 mg three times daily for 5–7 days when infection is confirmed.
- Vaccinations:
- Annual influenza vaccine (inactivated formulation).
- Pneumococcal conjugate (PCV13) followed by polysaccharide (PPSV23) boosters per CDC schedule.
- COVID‑19 vaccination – recommended for all patients.
Immunoglobulin Replacement
- Standard IgG replacement therapy (IVIG or subcutaneous) is **not** routinely indicated because IgA deficiency alone does not cause low IgG.
- However, if a patient develops concurrent IgG subclass deficiency or severe recurrent infections despite other measures, IgG therapy may be trialed under specialist supervision.
Autoimmune & Allergic Disease Management
- Standard disease‑specific therapies (e.g., levothyroxine for hypothyroidism, disease‑modifying antirheumatic drugs for rheumatoid arthritis).
- Allergy immunotherapy can be used, but clinicians should monitor for anaphylaxis because some IgA‑deficient patients develop anti‑IgA antibodies.
Lifestyle & Supportive Measures
- Good hand hygiene and avoidance of close contact with individuals who have respiratory infections.
- Hydration and balanced nutrition to support mucosal barrier integrity.
- Smoking cessation – dramatically lowers risk of respiratory infections.
Living with Immunoglobulin A Deficiency
While IgA deficiency is a chronic condition, most people lead active, healthy lives with appropriate precautions.
Daily Management Tips
- Track infections: Keep a log of respiratory or gastrointestinal episodes, the antibiotics used, and duration. Share this with your healthcare team.
- Vaccination calendar: Use a smartphone reminder or a printed schedule to stay up‑to‑date.
- Dental care: Regular dental check‑ups reduce the risk of chronic oral infections that can seed the sinuses.
- Nutrition: Emphasize probiotic‑rich foods (yogurt, kefir, sauerkraut) to promote gut flora; consider a diet low in processed sugars that can exacerbate yeast overgrowth.
- Exercise: Moderate aerobic activity improves immune surveillance. Avoid over‑training, which may transiently suppress immunity.
- Travel precautions: Carry a written summary of your condition, a list of current medications, and a short‑course antibiotic kit (if prescribed) for remote locations.
Psychosocial Support
- Join patient advocacy groups such as the Immune Deficiency Foundation (IDF) for peer support.
- Consider counseling if recurrent illness leads to anxiety or depression.
Prevention
Because IgA deficiency is largely genetic, true primary prevention is not possible. However, secondary prevention—reducing the risk of infections and complications—can be achieved.
- Adhere to recommended vaccination schedules.
- Practice rigorous hand‑washing and respiratory etiquette.
- Avoid exposure to known gastrointestinal pathogens (e.g., untreated water, raw shellfish).
- Promptly treat any upper‑airway infection to prevent progression.
- Monitor and manage co‑existing allergic or autoimmune conditions early.
Complications
If untreated or poorly managed, IgA deficiency can lead to several serious health problems.
- Chronic lung disease: Recurrent pneumonia can cause bronchiectasis, a permanent dilatation of the bronchi.
- Gastrointestinal disorders: Persistent Giardia infection may cause malabsorption, weight loss, and nutrient deficiencies.
- Autoimmune sequelae: Increased likelihood of developing systemic lupus erythematosus, rheumatoid arthritis, or autoimmune thyroid disease.
- Anaphylaxis to blood products: Patients with anti‑IgA antibodies may experience severe reactions to plasma‑derived products, including IVIG.
- Growth retardation in children: Due to chronic infection or malabsorption.
When to Seek Emergency Care
Call 911 or go to the nearest emergency department if you experience any of the following:
- Rapid onset of difficulty breathing, wheezing, or throat swelling after a transfusion or infusion.
- Sudden high‑grade fever (> 39.5 °C / 103 °F) with neck stiffness, severe headache, or altered mental status—possible meningitis.
- Severe abdominal pain with vomiting and diarrhea that does not improve after 24 hours—risk of dehydration or intestinal perforation.
- Unexplained fainting, chest pain, or palpitations accompanied by fever—could indicate sepsis.
- Bleeding gums, blood in stool, or persistent nosebleeds that do not stop after 20 minutes.
These signs may signal life‑threatening infection, anaphylaxis, or severe autoimmune complications that require immediate medical intervention.
References
- Mayo Clinic. IgA deficiency. https://www.mayoclinic.org/diseases-conditions/iga-deficiency/symptoms-causes/syc-20355779 (accessed June 2026).
- Centers for Disease Control and Prevention. Immunodeficiency: Primary Immunodeficiency Diseases. https://www.cdc.gov/immune/primary.html (accessed June 2026).
- National Institutes of Health. “Genetic basis of selective IgA deficiency.” Frontiers in Immunology 2021;12:635631. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823675/.
- Cleveland Clinic. IgA Deficiency. https://my.clevelandclinic.org/health/diseases/23655-immunoglobulin-a-deficiency (accessed June 2026).
- World Health Organization. Vaccination against influenza and pneumococcal disease for immunocompromised persons. WHO Guidelines 2022.
- Immune Deficiency Foundation. Living with IgA deficiency. https://primaryimmune.org (accessed June 2026).